-
公开(公告)号:CZ286187B6
公开(公告)日:2000-02-16
申请号:CZ283097
申请日:1997-09-08
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJOERG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00
Abstract: In the present invention there is disclosed a pharmaceutical preparation intended for treating proteinuria and containing as an active substance a combination of trandolapril and verapamil.
-
2.
公开(公告)号:AT105301T
公开(公告)日:1994-05-15
申请号:AT89105371
申请日:1981-08-22
Applicant: HOECHST AG
-
公开(公告)号:DE58906338D1
公开(公告)日:1994-01-20
申请号:DE58906338
申请日:1989-05-23
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , URBACH HANSJOERG DR , TEETZ VOLKER DR , ENGLERT HEINRICH CHRISTIAN DR , MANIA DIETER DR
Abstract: The invention relates to combinations of angiotensin converting enzyme inhibitors with potassium channel modulators, process for the preparation thereof and their use as medicines.
-
公开(公告)号:DK0417473T3
公开(公告)日:1993-12-13
申请号:DK90115230
申请日:1990-08-08
Applicant: HOECHST AG
Inventor: LINZ WOLFGANG DR , SCHOLZ WOLFGANG DR , URBACH HANSJOERG DR , SCHOELKENS BERNWARD PROF DR , WIEMER GABRIELE DR , HENNING RAINER DR , TEETZ VOLKER DR
Abstract: The invention relates to a method for the treatment of cardiac and of vascular hypertrophy and hyperplasia by administration of angiotensin converting enzyme inhibitors. Administration of compounds of the formula I (I) in which n is 1 or 2, R, R1, R2 and R3 are identical or different and each is hydrogen or an organic radical, and R4 and R5 form, together with the atoms carrying them, a mono-, bi- or tricyclic heterocyclic ring system, is preferred. The invention additionally relates to angiotensin converting enzyme inhibitors and to agents containing these for administration for the treatment of the abovementioned diseases.
-
5.
公开(公告)号:AT94409T
公开(公告)日:1993-10-15
申请号:AT90115230
申请日:1990-08-08
Applicant: HOECHST AG
-
公开(公告)号:CS9003958A3
公开(公告)日:1992-08-12
申请号:CS395890
申请日:1990-08-10
Applicant: HOECHST AG
Inventor: LINZ WOLFGANG DR , SCHOLKENS BERNWARD PROF DR , SCHOLZ WOLFGANG DR , WIEMER GABRIELE DR , URBACH HANSJORG DR , HENNING RAINER DR , TEETZ VOLKER DR
CPC classification number: A61K38/556
-
公开(公告)号:CS9103587A3
公开(公告)日:1992-06-17
申请号:CS358791
申请日:1991-11-26
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJORG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , A61K37/64 , A61K31/44
CPC classification number: A61K38/556 , A61K31/44 , A61K31/55 , A61K31/275 , A61K2300/00
-
公开(公告)号:CS358791A3
公开(公告)日:1992-06-17
申请号:CS358791
申请日:1991-11-26
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJORG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , A61K37/64 , A61K31/44
Abstract: An angiotensin converting enzyme inhibitor (I) can be used in combination with Ca antagonists (III) in the prevention and therapy of proteinuria. Pref. (A) Ramipril and felodipine; (B) Ramipril and 4-(2,3-dichlorophenyl) -2,6-dimethyl-3- (1,2,4-oxadiazol-5-yl) -S-isopropoxy carbonyl-1,4-dihydropyridine (IIb), (c) Trandolapril and felodipine; (D) Trandolapril and (IIb), (E) Trandolapril and Verapamil; (F) Quinapril and felodipine; (G) Quinapril and (IIIb) or the physiologically acceptable salts of these components.
-
公开(公告)号:CS409591A3
公开(公告)日:1992-04-15
申请号:CS409591
申请日:1991-12-27
Applicant: HOECHST AG
Inventor: URBACH HANSJORG DR , HENNING RAINER DR , TEETZ VOLKER DR , GEIGER ROLF PROF DR , BECKER REINHARD DR , GAUL HOLGER
IPC: A61K38/55 , A61K31/40 , A61K31/403 , A61K31/404 , A61K38/00 , A61P7/10 , A61P9/08 , A61P9/12 , C07D209/02 , C07D209/08 , C07D209/32 , C07D209/34 , C07D209/42 , C07D209/52 , C07D215/22 , C07D215/227 , C07K1/02 , C07K1/113 , C07K5/02 , C07K5/06
Abstract: 1. Claims for the Contracting states ; BE, CH, DE, FR, GB, IT, Li, Lu, NL, SE A compound of the formula I see diagramm : EP0084164,P21,F7 in which the hydrogen atoms on the bridgehead C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2, R1 denotes methyl, R2 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen and X denotes phenyl, and its physiologically acceptable salts. 1. Claims for the Contracting state : Austria A process for the preparation of the compounds of the formula I see diagramm : EP0084164,P24,F4 in which the hydrogen atoms on the bridgehead C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2, R1 denotes methyl, R2 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen and X denotes phenyl, and its physiologically acceptable salts, which a) comprises reacting a compound of the formula II see diagramm : EP0084164,P24,F6 wherein R1 , R2 , X, Y and Z have the meanings as in formula I, with a compound of the formula III see diagramm : EP0084164,P25,F1 in which the H atoms on the C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n denotes 0, 1 or 2 and W denotes a radical which can be cleaved off by hydrogenolysis or by acid, and subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl groups, or b) for the preparation of compounds of the formula I, in which Y and Z together denote oxygen, comprises b1 ) reacting a compound of the formula IV see diagramm : EP0084164,P25,F3 in which the H atoms on the C atoms 3a and (6+n)a have the trans configuration relative to one another and wherein n and R1 have the meanings as in formula I and W has the meaning as in formula III, with a compound of the formula V, R2 O2 C-CH = CH-CO-X wherein R2 and X have the meanings as in formula I, and subsequently splitting off the radical W and, if appropriate, also the radical R2 to form the free carboxyl groups, or, b2 ) reacting a compound of the formula IV mentioned under b1 ) with a compound of the general formula VI, wherein R2 has the meaning as in formula I, and with a compound of the general formula VII OHC-CO2 R2 X-CO-CH3 wherein X has the meaning as in formula I, subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl group, or c) for the preparation of compounds of the formula I, in which Y and Z each denote hydrogen, comprises c1 ) reacting a compound of the formula IV mentioned under b1 ) with a compound of the formula VIII see diagramm : EP0084164,P25,F2 wherein R2 and X have the meanings as in formula I, reducing the Schiff's bases obtained and subsequently splitting off the radical W and, if appropriate, the radical R2 to form the free carboxyl groups, or c2 ) catalytically reducing a compound of the formula I in which Y and Z together denote oxygen, with hydrogen, or d) for the preparation of compounds of the formula I, in which Y denotes hydroxyl and Z denotes hydrogen, comprises reducing a compound of the formula I, in which Y and Z together denote oxygen, catalytically with hydrogen or with a reducing agent, such as sodium borohydride, and, if appropriate, converting the compounds obtained according to (a)-(d) into their physiologically acceptable salts.
-
公开(公告)号:AT73818T
公开(公告)日:1992-04-15
申请号:AT86116325
申请日:1986-11-25
Applicant: HOECHST AG
Inventor: KOENIG WOLFGANG DR , TEETZ VOLKER DR
IPC: C07K1/06 , C07K1/10 , C07K7/00 , C07K7/06 , C07K14/575 , C07K14/645
-
-
-
-
-
-
-
-
-